Yttrium (90y) Colloïdensuspensie Cis Bio International

Yttrium (90Y) Citrate is a radiopharmaceutical used for intraarticular therapy, particularly in synovitis treatment. This colloidal suspension targets inflamed joints with localized radiation. Suitable for patients seeking targeted pain relief options.

Yttrium (90Y) Citrate is primarily used for intraarticular injection to manage synovitis, a condition characterized by joint inflammation. It is often considered when conventional therapies have not provided adequate relief. This treatment is typically used in larger joints like the knee. Patients often ask, 'what is Yttrium (90Y) Citrate used for' to understand its role in managing joint-related discomfort.

After administration, Yttrium (90Y) Citrate emits beta radiation to reduce inflammation within the joint space. Patients may experience gradual improvement in joint mobility and pain reduction over several weeks. The effects are localized, minimizing impact on surrounding tissues. Some may notice temporary post-procedure discomfort as the treatment takes effect.

Yttrium (90Y) Citrate should only be handled and administered by trained healthcare professionals in a controlled setting. Proper shielding and protective measures are required to minimize radiation exposure. Patients should avoid close contact with others, especially children and pregnant individuals, for a specified period post-treatment. Disposal must follow strict radioactive material protocols.

As a radiopharmaceutical, Yttrium (90Y) Citrate does not interact with medications in the traditional sense. However, prior radiation therapy or recent joint surgeries may influence treatment decisions. Patients should inform their healthcare provider about all current medications and medical history. Concomitant use of other intraarticular therapies may require careful timing to avoid overlapping effects.